Table 2.
Bcl6 region assayed | Male | Female | Male + GHcont | Male-female ratio | |
---|---|---|---|---|---|
hnRNA | Intron 1–exon 4 | 134 ± 34 | 654 ± 163 | 614 ± 150 | 0.21 ± 0.02 |
Intron 4–exon 5 | 48 ± 7 | 29 ± 8 | 33 ± 10 | 1.8 ± 0.5 | |
Exon 5–exon 10 | 23 ± 3 | 2.0 ± 0.7 | 1.6 ± 0.3 | 12 ± 4 | |
mRNA | Exon 9–intron 9 | 27.1 ± 6.9 | 1.00 ± 0.15 | 1.67 ± 0.11 | 27.1 ± 6.9 |
Relative levels of liver Bcl6 hnRNA presented in Fig. 4B were averaged across three distinct regions of the Bcl6 gene: intron 1 through exon 4 (primer pairs numbered 2–7 in Fig. 4B), intron 4 through exon 5 (primer pairs 9–18), and exon 5 through exon 10 (primers pairs 19–22); data shown are mean ± sd values. Relative levels of Bcl6 mRNA (mean ± se.) are based on Fig. 1D. Based on these data, the transcriptional block in female liver and in continuous GH-treated (GHcont) male liver decreased steady-state levels of Bcl6 hnRNA sequences beyond exon 5 by 325-fold (in females; i.e. 654/2.0) or by 380-fold (in continuous GH-treated males; i.e. 614/1.6) when compared with hnRNA sequences before intron 4. The corresponding decrease in hnRNA transcript levels across the gene in male liver was only 5.8-fold (i.e. 134/23), which may reflect increased processing of the longer transcripts to mature mRNA.